ImmuPharma plc (AIM:IMM)
London flag London · Delayed Price · Currency is GBP · Price in GBX
6.72
-0.23 (-3.31%)
Mar 5, 2026, 9:37 AM GMT

ImmuPharma Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
355761733
Market Cap Growth
82.39%-27.71%13.16%-62.85%-50.56%24.75%
Enterprise Value
354761333
Last Close Price
0.070.010.020.020.070.13
PS Ratio
----139.54263.72
PB Ratio
103.77-9.246.572.433.743.46
P/TBV Ratio
105.34-6.852.503.813.49
EV/Sales Ratio
----109.19257.02
Debt / Equity Ratio
---000.07
Net Debt / Equity Ratio
-1.180.44-0.20-0.26-0.37-0.54
Net Debt / EBITDA Ratio
0.130.090.070.230.330.96
Net Debt / FCF Ratio
0.210.130.150.270.341.42
Asset Turnover
----0.010.02
Quick Ratio
0.730.440.541.391.765.03
Current Ratio
1.210.580.811.612.115.89
Return on Equity (ROE)
-259.88%-967.41%-163.24%-109.77%-116.20%-91.93%
Return on Assets (ROA)
-69.57%-90.42%-57.18%-37.97%-38.13%-41.80%
Return on Capital Employed (ROCE)
-932.90%492.80%-290.00%-120.00%-116.90%-57.90%
Earnings Yield
-11.26%-49.49%-42.09%-62.07%-49.49%-20.54%
FCF Yield
-5.44%-35.29%-19.65%-39.99%-29.57%-11.04%
Buyback Yield / Dilution
-11.05%-15.04%-19.51%-20.60%-25.47%-30.45%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.